[Comment] The long-term efficacy of a respiratory syncytial virus vaccine for older adults
Respiratory syncytial virus (RSV) remains a major cause of life-threatening respiratory illness in older adults. Estimates suggest that more than 30 000 adults older than 60 years die from RSV every year in high-income countries.1 However, after almost...